Results 81 to 90 of about 105,081 (322)

PARATYPHOID CHOLECYSTITIS [PDF]

open access: yesArchives of Internal Medicine, 1910
n ...
openaire   +2 more sources

A Retrospective Study on Use of Neutrophil‐Lymphocyte Ratio as a Prognostic Measurement to Assess Acute Diverticulitis

open access: yesANZ Journal of Surgery, EarlyView.
Graphical abstract representation of Neutrophil‐lymphocyte ratio use as a prognostic marker in acute diverticulitis. ABSTRACT Background Acute diverticulitis (AD) is a common surgical condition and the Neutrophil‐lymphocyte ratio (NLR) is an emerging biomarker ratio used to guide its management.
Yam Ting Ho   +9 more
wiley   +1 more source

ACUTE CHOLECYSTITIS

open access: yesThe Professional Medical Journal, 2009
Laparoscopic cholecystectomy has been accepted as the treatment of choice for symptomatic gallstones. Its efficacy and timingin cases of acute cholecystitis is still under debate. This study was undertaken to evaluate our experience with early cholecystectomy as a safe,effective treatment of acute cholecystitis.
Muhammad Faisal Bilal Lodh   +2 more
openaire   +2 more sources

Comparing the Diagnostic Accuracy of Ultrasound and CT in Evaluating Acute Cholecystitis.

open access: yesAJR. American journal of roentgenology, 2018
OBJECTIVE In 2013, a multidisciplinary group at our Veterans Administration hospital collaborated to improve the diagnosis and treatment of patients with acute cholecystitis (AC) at our facility.
Joss R Wertz   +3 more
semanticscholar   +1 more source

Serious adverse events associated with bowel preparation for colonoscopy in Japan: Systematic review

open access: yesDigestive Endoscopy, EarlyView.
Objectives Bowel preparation for colonoscopy can lead to serious adverse events (AEs), raising significant safety concerns in colorectal cancer (CRC) screening. A systematic review of these serious AEs in Japan was performed to explore potential management strategies.
Toshihiro Tadano   +8 more
wiley   +1 more source

Is There a Correlation between Helicobacter Pylori and Enterohepatic Helicobacter Species and Gallstone Cholecystitis?

open access: yesMiddle East Journal of Digestive Diseases, 2018
BACKGROUND Cholecystitis is a common surgical condition. Recently, several authors have reported that DNA of bile tolerant Helicobacter spp. has been found in the human bile colonizing the biliary tract.
Seyed Masih Fatemi   +7 more
doaj   +1 more source

Gallbladder cancer: South American experience [PDF]

open access: yes, 2016
Large differences in terms of incidence and mortality due to gallbladder cancer (GBC) have been reported worldwide. Moreover, it seems that GBC has unique characteristics in South America.
Arroyo, Gerardo F.   +2 more
core   +1 more source

Endoscopic Ultrasound-Guided Gallbladder Drainage Using a Lumen-Apposing Metal Stent for Acute Cholecystitis: A Systematic Review

open access: yesClinical Endoscopy, 2018
Surgery remains the standard treatment for acute cholecystitis except in high-risk candidates where percutaneous transhepatic gallbladder drainage (PT-GBD), endoscopic transpapillary cystic duct stenting (ET-CDS), and endoscopic ultrasound-guided ...
Deepanshu Jain   +3 more
semanticscholar   +1 more source

Tirzepatide and cardiometabolic parameters in obesity: Summary of current evidence

open access: yesDiabetes, Obesity and Metabolism, EarlyView.
Abstract Globally, cardiovascular diseases (CVDs) account for around one‐third of all deaths. Clinical trial evidence suggests that treatment of people with obesity or type 2 diabetes (T2D) and CVD with glucagon‐like peptide‐1 (GLP‐1) receptor agonists reduces the risk of major adverse cardiovascular events, heart failure outcomes and all‐cause ...
Naveed Sattar   +5 more
wiley   +1 more source

Haemophilia Prophylaxis in the Age of Innovation: Exploring Opportunities for Personalized Treatment

open access: yesHaemophilia, EarlyView.
ABSTRACT Introduction Recent advancements in haemophilia treatment have introduced a range of innovative therapies, including activated FVIII mimetics, ultra‐extended half‐life recombinant FVIII, rebalancing agents and gene therapy. These developments have transformed treatment options and expanded prophylaxis strategies.
Yesim Dargaud   +5 more
wiley   +1 more source

Home - About - Disclaimer - Privacy